Molecular Testing in Emerging Infectious Diseases

J. Dong; N. Ismail; D. H. Walker

doi:10.1016/B978-0-12-800886-7.00015-7

Molecular Testing in Emerging Infectious Diseases

J. Dong, N. Ismail, D. H. Walker

Pathology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

It was widely believed in the late 1960s that infectious diseases had been conquered by vaccines and antibiotics and humans were no longer under threat by microbial pathogens. Yet, since that time more than 60 pathogens have been discovered that can cause serious emerging infectious diseases. Molecular methods have played critical roles in the discovery, monitoring, and clinical diagnostics of emerging pathogens. In this chapter, we present well-recognized emerging pathogens. We provide examples of the utility of molecular assays in research and clinical care of emerging infectious diseases. We also discuss some theoretical and practical limitations of molecular tests and the future prospects of expanding molecular diagnostics for emerging pathogens based on new advances of knowledge and technologies.

Original language	English (US)
Title of host publication	Diagnostic Molecular Pathology
Subtitle of host publication	A Guide to Applied Molecular Testing
Publisher	Elsevier
Pages	179-200
Number of pages	22
ISBN (Electronic)	9780128008867
ISBN (Print)	9780128011577
DOIs	https://doi.org/10.1016/B978-0-12-800886-7.00015-7
State	Published - Jan 1 2016

Keywords

emerging infectious diseases
emerging pathogens
Molecular diagnostics
molecular methods
molecular tests

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/B978-0-12-800886-7.00015-7

Cite this

@inbook{89f17e936de34215945bc34f29425ab2,

title = "Molecular Testing in Emerging Infectious Diseases",

abstract = "It was widely believed in the late 1960s that infectious diseases had been conquered by vaccines and antibiotics and humans were no longer under threat by microbial pathogens. Yet, since that time more than 60 pathogens have been discovered that can cause serious emerging infectious diseases. Molecular methods have played critical roles in the discovery, monitoring, and clinical diagnostics of emerging pathogens. In this chapter, we present well-recognized emerging pathogens. We provide examples of the utility of molecular assays in research and clinical care of emerging infectious diseases. We also discuss some theoretical and practical limitations of molecular tests and the future prospects of expanding molecular diagnostics for emerging pathogens based on new advances of knowledge and technologies.",

keywords = "emerging infectious diseases, emerging pathogens, Molecular diagnostics, molecular methods, molecular tests",

author = "J. Dong and N. Ismail and Walker, {D. H.}",

year = "2016",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-800886-7.00015-7",

language = "English (US)",

isbn = "9780128011577",

pages = "179--200",

booktitle = "Diagnostic Molecular Pathology",

publisher = "Elsevier",

}

TY - CHAP

T1 - Molecular Testing in Emerging Infectious Diseases

AU - Dong, J.

AU - Ismail, N.

AU - Walker, D. H.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - It was widely believed in the late 1960s that infectious diseases had been conquered by vaccines and antibiotics and humans were no longer under threat by microbial pathogens. Yet, since that time more than 60 pathogens have been discovered that can cause serious emerging infectious diseases. Molecular methods have played critical roles in the discovery, monitoring, and clinical diagnostics of emerging pathogens. In this chapter, we present well-recognized emerging pathogens. We provide examples of the utility of molecular assays in research and clinical care of emerging infectious diseases. We also discuss some theoretical and practical limitations of molecular tests and the future prospects of expanding molecular diagnostics for emerging pathogens based on new advances of knowledge and technologies.

AB - It was widely believed in the late 1960s that infectious diseases had been conquered by vaccines and antibiotics and humans were no longer under threat by microbial pathogens. Yet, since that time more than 60 pathogens have been discovered that can cause serious emerging infectious diseases. Molecular methods have played critical roles in the discovery, monitoring, and clinical diagnostics of emerging pathogens. In this chapter, we present well-recognized emerging pathogens. We provide examples of the utility of molecular assays in research and clinical care of emerging infectious diseases. We also discuss some theoretical and practical limitations of molecular tests and the future prospects of expanding molecular diagnostics for emerging pathogens based on new advances of knowledge and technologies.

KW - emerging infectious diseases

KW - emerging pathogens

KW - Molecular diagnostics

KW - molecular methods

KW - molecular tests

UR - http://www.scopus.com/inward/record.url?scp=85103532997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103532997&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800886-7.00015-7

DO - 10.1016/B978-0-12-800886-7.00015-7

M3 - Chapter

AN - SCOPUS:85103532997

SN - 9780128011577

SP - 179

EP - 200

BT - Diagnostic Molecular Pathology

PB - Elsevier

ER -

Molecular Testing in Emerging Infectious Diseases

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this